Arkolith/Insider Trading/RCKT/Form 4

Schwartz Jonathan David

See RemarksROCKET PHARMACEUTICALS, INC. (RCKT) · full profile →Form 4 · filed Nov 20, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2025Sell(S)3K$2.98$8K299K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-042856) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML